| 000 | 01055 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516074824.0 | ||
| 264 | 0 | _c20160422 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1948-2124 | ||
| 024 | 7 |
_a10.5731/pdajpst.2011.00845 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEltermann, John | |
| 245 | 0 | 0 |
_aAdventitious Agents: Issues and Considerations during Pre-Approval Reviews and Inspections. _h[electronic resource] |
| 260 |
_bPDA journal of pharmaceutical science and technology _c |
||
| 300 |
_a694-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aBiological Products |
| 650 | 0 | 4 | _aConsumer Product Safety |
| 650 | 0 | 4 |
_aDrug Contamination _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRisk Management |
| 650 | 0 | 4 | _aSan Francisco |
| 650 | 0 | 4 | _aViruses |
| 773 | 0 |
_tPDA journal of pharmaceutical science and technology _gvol. 65 _gno. 6 _gp. 694-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5731/pdajpst.2011.00845 _zAvailable from publisher's website |
| 999 |
_c21507701 _d21507701 |
||